Lubiprostone
NDC 70771-1764, Lubiprostone, capsule, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1764
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214131
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1764 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LUBIPROSTONE24 ug/1
Pharmacologic classes
Chloride Channel Activator [EPC]; Chloride Channel Activators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1764-1 | 70771176401 | 100 CAPSULE in 1 BOTTLE (70771-1764-1) |
| 70771-1764-6 | 70771176406 | 60 CAPSULE in 1 BOTTLE (70771-1764-6) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/81f9c9de-f89d-4ab0-a8ca-18d3691e42f9
Use it
Look up 70771-1764 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1764 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1764. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.